Publication | Open Access
Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons <i>In Vitro</i> and Enhances Dopamine Release <i>In Vivo</i>
38
Citations
51
References
2019
Year
The GDNF receptor RET agonist BT13 demonstrates the potential for further development of novel disease-modifying treatments against PD. © 2019 International Parkinson and Movement Disorder Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1